Navigation Links
Ridge Diagnostics, Inc. CEO to Speak at Neurotech Investing and Partnering Conference
Date:5/5/2011

SAN DIEGO, May 5, 2011 /PRNewswire/ -- Ridge Diagnostics, Inc., a neurodiagnostic company, announced that Lonna J. Williams, CEO will speak at the 6th Annual Neurotech Investing and Partnering Conference to be held in San Francisco, CA at the St. Regis Hotel on May 9th and 10th.  

Ms. Williams, a clinical diagnostics industry veteran, will participate on a panel entitled "Next Generation Psychiatry" lead by Dr. Manuel Lopez-Figueroa, Vice President, Bay City Capital. The panel will discuss the most promising next generation diagnostics, devices and treatments for neuropsychiatric disorders such as depression, schizophrenia, anxiety, addiction and others.

Ridge Diagnostics develops and sells blood tests which aid in the diagnosis and management of clinical depression or Major Depressive Disorder.  For the first time, a blood test provides clinicians and patients with objective, biologically based, diagnostic information to manage and treat this disorder.    Blood test results are intended to augment the current tools used for neuropsychiatric diagnosis and patient management.  Additional tests are in development for antidepressant efficacy monitoring and adolescent depression.

Ridge Diagnostics, Inc. Ridge Diagnostics is a neurodiagnostic company developing and marketing blood-based tests to diagnose and monitor neuropsychiatric disorders.  Ridge has commercialized the first-in-class, proprietary blood test for the diagnosis and treatment monitoring of Major Depressive Disorder (MDD).   The portfolio of neurodiagnostic blood tests are based on a proprietary Human Biomarker Library and Hyper-Mapping technology.  The testing services are provided by the Ridge owned CLIA laboratory. The company is located in San Diego, CA and Research Triangle Park, NC.   www.ridgedx.com

Neurotech Investing and Partnering Conference. The premier partnering and investing conference where investors, executives, entrepreneurs, scientists and others involved in the development of new treatments and diagnostics for the brain and nervous system come together to shape the future of their organization and the industry. Find out about next generation drugs, devices and diagnostics for Alzheimer's, addiction, anxiety, depression, Huntington's, ALS, pain, sensory disorders, obesity, stroke, schizophrenia, sleep disorders, epilepsy, multiple sclerosis, traumatic brain injury, spinal cord injury, Parkinson's and more.


'/>"/>
SOURCE Ridge Diagnostics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. HeartWare Reports Additional Data from Bridge-to-Transplant Clinical Trial and Continued Access Patients
2. Cempra Pharmaceuticals to Present at Two Upcoming Cambridge Healthtech Institute (CHI) Conferences
3. Breckenridge Pharmaceutical Enters Agreement with Oman Pharmaceutical Products Company LLC
4. BridgePoint Medical Names Industry Veteran as Chief Executive Officer
5. BridgePoint Medical Closes $9.1 Million Series C Financing
6. Sunridge Signs Distribution Agreement for Turkey
7. HeartWare Receives Third Patient Allotment From FDA - Authorizing 94 Additional Patients - Under Continued Access Protocol for Pivotal U.S. Bridge-to-Transplant Clinical Trial
8. Sunridge Moves Forward to Open Company Owned Clinics
9. Rockbridge Growth Equity Leads Acquisition of Connect America, a Leading Direct to Consumer Provider of Personal Emergency Response Systems (PERS)
10. HeartWare Files PMA Application for FDA Approval of the HeartWare® Ventricular Assist System for a Bridge-to-Transplant Indication
11. Caliper Life Sciences to Acquire Cambridge Research & Instrumentation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... Calif. , June 24, 2016  American Respiratory Labs (ARL), ... is now able to perform sophisticated lung assessments in patients, homes, ... , Inc. Patients are no longer limited to ... EasyOne PRO ® , ARL patients like Jeanne R. of ... in the comfort of her own home. ...
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ... company developing innovative inhaled drugs, announced today that it ... Russell Investments reconstituted its comprehensive set of U.S. ... "This is an important milestone for Pulmatrix," said ... increase shareholder awareness of our progress in developing drugs ...
(Date:6/23/2016)... 2016  MedSource announced today that it has ... solution of choice.  This latest decision demonstrates MedSource,s ... their clients by offering a state-of-the-art electronic data ... nowEDC as the EDC platform of choice in ... "nowEDC has long been a preferred EDC platform ...
Breaking Medicine Technology:
(Date:6/24/2016)... ... June 24, 2016 , ... The ... in Dallas that it will receive two significant new grants to support its ... PHA marked its 25th anniversary by recognizing patients, medical professionals and scientists for ...
(Date:6/24/2016)... ... ... People across the U.S. are sharpening their pencils and honing their writing ... which patients and their families pay tribute to a genetic counselor by nominating him ... Genetic Counselors (NSGC) Annual Education Conference (AEC) this September. , In April, Genome ...
(Date:6/24/2016)... ... June 24, 2016 , ... National recruitment firm ... sciences executive with extensive sequencing and genomics experience, as Vice President of North American ... Hill will be responsible for leading the sales team in the commercialization of the ...
(Date:6/24/2016)... ... June 24, 2016 , ... To succeed under value-based payments, ... are unsure how to move forward, given the need to sustain current operations. ... tailored to an organization’s specific needs. , PYA Principal Martie Ross states, “Healthcare ...
(Date:6/23/2016)... ... June 23, 2016 , ... Terumo BCT, ... organization responsible for clinical transfusion research programs and for the blood supply in ... Evaluation and Predictive Analytical Rating Score (PREPAReS) study. , Currently in its ...
Breaking Medicine News(10 mins):